AstraZeneca to supply 31m COVID-19 shots to EU in first quarter


AstraZeneca Plc has informed European Union officials on Friday it would cut deliveries of its COVID-19 vaccine to the bloc by 60% to 31 million doses in the first quarter of the year due to production problems, a senior official told Reuters.
The decrease deals another blow to Europe’s COVID-19 vaccination drive after Pfizer Inc and partner BioNTech SE slowed supplies of their vaccine to the bloc this week, saying the move was needed because of work to ramp up production.
AstraZeneca was expected to deliver about 80 million doses to the 27 EU countries by the end of March, the official who was involved in the talks said.
The official added AstraZeneca planned to begin deliveries to the EU from Feb. 15, in line with original plans.
The company confirmed the drop in deliveries without giving specific details on the magnitude of the shortfall.
“Initial volumes will be lower than originally anticipated due to reduced yields at a manufacturing site within our European supply chain,” an AstraZeneca spokesman said in a written statement.
“We will be supplying tens of millions of doses in February and March to the European Union, as we continue to ramp up production volumes,” he said of the vaccine developed with Oxford University.
The Britain-based drugmaker had also agreed to deliver more than 80 million doses in the second quarter. On Friday, the EU official, who spoke under condition of anonymity, said the company was not able to provide updated delivery targets for the April to June period due to the production issues.
AstraZeneca told EU officials at a meeting that the cut was due to production problems at a vaccine factory in Belgium run by its partner Novasep, the EU official said. Novasep was not immediately available to comment.
EU governments “expressed deep dissatisfaction with this,” EU Health Commissioner Stella Kyriakides said on Twitter after the announcement.
The EU drug regulator is due to decide on approval of AstraZeneca’s vaccine on Jan. 29. It has already received emergency authorisation in Britain.
The EU has a deal to purchase at least 300 million doses from AstraZeneca, with an option for an additional 100 million, part of the company’s global commitments to supply more than 3 billion doses.


Abuja Man reveals (FREE) secret Fruits that Increased his Manh00d size and Lasting Power in 5days…


%d bloggers like this:
Fake Richard Mille Replica Watches, The ceramic upper and lower cases are imported from Taiwan and are processed by ATPT ceramics to form Y-TZP ceramics. After high-tech anti-fingerprint technology, they present a delicate and soft sub-black material. This color quality has remained unchanged for a hundred years. The color and luster are more detailed to achieve the ceramic tone visual pattern electroplating upper and lower shells that are infinitely close to the original products, with anti-reflective coating sapphire glass! The tape uses a soft and delicate Malaysian imported top rubber strap, and the movement is equipped with an imported Seiko NH movement. The buckle of this version is made according to the original size and thinness, making it feel more comfortable and intimate, the highest version on the market Richard Mille Replica